Mankind Pharma

2,395.60
-59.85
(-2.44%)
Market Cap (₹ Cr.)
₹98,296
52 Week High
2,564.95
Book Value
₹234
52 Week Low
1,683.05
PE Ratio
50.09
PB Ratio
10.50
PE for Sector
39.11
PB for Sector
4.60
ROE
20.28 %
ROCE
45.10 %
Dividend Yield
0.00 %
EPS
₹48.99
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
19.57 %
Net Income Growth
48.26 %
Cash Flow Change
18.70 %
ROE
18.03 %
ROCE
41.60 %
EBITDA Margin (Avg.)
16.06 %

Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
1,653
2,080
2,327
1,969
1,915
2,179
2,511
2,426
2,104
2,527
Expenses
1,336
1,641
1,735
1,563
1,491
1,594
1,818
1,755
1,481
1,831
EBITDA
317
439
591
406
424
585
693
670
623
696
Operating Profit %
19 %
20 %
23 %
19 %
20 %
24 %
26 %
26 %
26 %
24 %
Depreciation
36
65
66
71
67
69
77
90
82
83
Interest
11
9
8
9
1
2
4
4
4
6
Profit Before Tax
270
365
517
326
355
514
612
576
536
607
Tax
1
54
89
67
81
91
122
74
105
108
Net Profit
217
298
420
249
281
409
473
487
454
513
EPS in ₹
5.43
7.44
10.49
6.21
7.01
10.22
11.80
12.16
11.34
12.82

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
Total Assets
4,531
5,880
8,939
9,371
11,418
Fixed Assets
945
987
2,927
3,142
3,404
Current Assets
1,949
3,090
3,816
3,517
5,490
Capital Work in Progress
148
166
387
495
188
Investments
1,784
2,397
2,526
3,102
4,430
Other Assets
1,655
2,330
3,100
2,632
3,396
Total Liabilities
880
1,146
2,398
1,587
1,794
Current Liabilities
816
1,079
2,271
1,419
1,593
Non Current Liabilities
64
67
127
168
201
Total Equity
3,651
4,734
6,540
7,784
9,624
Reserve & Surplus
3,611
4,694
6,500
7,744
9,584
Share Capital
40
40
40
40
40

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
31
-9
5
-55
40
48
55
Investing Activities
-516
-306
-396
-1,127
-1,360
-1,041
-1,919
Operating Activities
540
537
960
983
821
1,799
1,983
Financing Activities
8
-240
-559
89
579
-710
-9

Share Holding

% Holding
Sept 2022
Mar 2023
May 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
79.00 %
76.50 %
76.50 %
76.50 %
76.50 %
76.50 %
74.88 %
74.87 %
FIIs
0.00 %
2.61 %
2.61 %
4.18 %
4.18 %
6.74 %
9.87 %
11.58 %
DIIs
21.00 %
2.64 %
2.64 %
4.64 %
4.56 %
9.79 %
11.14 %
9.95 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
18.25 %
18.25 %
14.68 %
14.76 %
6.97 %
4.11 %
3.61 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,836.00 4,47,691.91 42.46 49,887.17 12.06 9,648 42.62 61.03
1,651.60 1,34,956.56 30.36 26,520.66 14.17 4,155 17.77 60.15
1,079.95 1,11,727.19 26.80 19,831.50 13.82 3,831 30.78 34.07
6,567.80 1,10,648.92 19.88 28,905.40 12.36 5,578 -0.90 36.38
2,224.95 1,03,570.56 45.76 20,141.50 19.94 1,936 77.69 59.35
2,395.60 98,296.04 50.09 10,615.63 19.57 1,942 9.89 53.00
1,539.15 90,940.60 25.35 29,559.25 17.55 3,169 61.17 55.58
6,090.30 74,370.03 34.59 12,978.42 9.84 1,811 91.18 53.74
1,646.05 48,348.71 - 12,653.09 6.58 -1,831 96.52 48.26
363.65 45,082.53 28.88 15,621.20 35.25 1,298 478.78 48.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
53.00
ATR(14)
Volatile
81.78
STOCH(9,6)
Neutral
36.62
STOCH RSI(14)
Oversold
1.40
MACD(12,26)
Bearish
-10.89
ADX(14)
Strong Trend
45.51
UO(9)
Bearish
36.16
ROC(12)
Uptrend And Accelerating
0.19
WillR(14)
Oversold
-87.32